31183-81-0Relevant articles and documents
-
Hodgson,Anderson
, p. 2195 (1924)
-
Catalytic enantioselective one-pot approach to cis- and trans-2,3-diaryl substituted 1,5-benzothiazepines
Meninno, Sara,Quaratesi, Ilaria,Volpe, Chiara,Mazzanti, Andrea,Lattanzi, Alessandra
supporting information, p. 6923 - 6934 (2018/10/17)
The first enantioselective catalytic approach to cis- and trans-2,3-diaryl substituted 1,5-benzothiazepines has been conveniently developed in a one-pot fashion, starting from α,β-unsaturated acyl pyrazoles and 2-aminothiophenol. The organocatalytic two-s
COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY
-
Paragraph 802-803, (2017/01/31)
The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.